Monday, May 21, 2012

Reportlinker Adds Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

May 15, 2010 by biotechconnection.com · Leave a Comment 

Reportlinker Adds Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
Reportlinker.com announces that a new market research report is available in its catalogue:
Read more on PR Newswire via Yahoo! Finance

India – The Next Biggest KPO Markets Worldwide

May 15, 2010 by biotechconnection.com · Leave a Comment 

KPO India has emerged as the more preferred knowledge process outsourcing destination for companies all over the world. The KPO industry has the advantage of some of the best Indian talents in the field which need special expertise, skills and knowledge.
About KPO
KPO is just the addition to offshore Business process outsourcing. KPO Indian is the [...]

Research and Markets: Licensing Opportunities: Neurology – the Future of Drug Discovery and Developments

Research and Markets: Licensing Opportunities: Neurology – the Future of Drug Discovery and Developments
DUBLIN—-Research and Markets has announced the addition of Decision Resources, Inc.’s new report “Licensing Opportunities: Neurology” to their offering.
Read more on Business Wire via Yahoo! Finance

The Cro Market Outlook: Emerging Markets, Leading Players And Future Trends-Aarkstore Enterprise

However, amongst other resistors, the financial crisis resulted in reduced funding available for biotech companies. This fully updated CRO Market Outlook assesses the market drivers and resistors and predicts the effects of these. The report analyzes the overarching trends in the industry; examines which regions are set to see growth in CRO activity; evaluates the [...]

Research and Markets: Stem Cell Technology Update: the Rise of Induced Pluripotent Stem Cells

Research and Markets: Stem Cell Technology Update: the Rise of Induced Pluripotent Stem Cells
DUBLIN—-Research and Markets has announced the addition of Decision Resources, Inc.’s new report “Stem Cell Technology Update: The Rise of Induced Pluripotent Stem Cells” to their offering.
Read more on Business Wire via Yahoo! Finance

Next Page »